A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
Conditions
- Herpes Zoster (HZ)
- Shingles
- Infectious Disease
Interventions
- BIOLOGICAL: JCXH-105
- BIOLOGICAL: Active Control (Shingrix)
Sponsor
Immorna Biotherapeutics, Inc.
Collaborators